共 50 条
- [7] Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma [J]. npj Precision Oncology, 7
- [9] Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report [J]. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2022, 8 (06):